Atlas Trials

Secondary Hyperparathyroidism (SHPT)

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Secondary Hyperparathyroidism (SHPT)

RecordFirmDate
Cardiovascular Mortality Prediction in Maintenance Hemodialysis Patients (NCT07769190)Huashan Hospital2021-07-16
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) (NCT04064827)AbbVie2020-09-16
Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) (NCT01453634)OPKO Health, Inc.2013-01-01

Track Secondary Hyperparathyroidism (SHPT) automatically

Every clearance here is in the API, with alerts when new ones post.